Global Smoking Cessation & Nicotine De-addiction Market By Product Type (With Nicotine {OTC Products [E-cigarettes (Open System and Closed System), Nicotine Gums (NRT), Nicotine Patches (NRT), Nicotine Lozenges (NRT) and Nicotine Tablets (NRT)] and Prescription Products [Nicotine Sprays (NRT) and Nicotine Inhalers (NRT)}) and (Without Nicotine {OTC Products [E-cigarettes (Open System and Closed System)] and Prescription Products (Zyban and Chantix)) By Distribution Channel (Online and Offline {Single-brand Vape Stores, Multi-brand Vape Stores and Retail Stores}) By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast 2019 - 2027
Industry Trend
The global smoking cessation & nicotine de-addiction market was valued at US$ 18,368.0 Mn in 2018 and is anticipated to grow at a CAGR of 24.5% to reach US$ 132,450.0 Mn in 2027. Global smoking cessation & nicotine de-addiction market consists of two product categories: NRT (Nicotine Replacement Therapy) products and e-cigarettes. NRT (Nicotine Replacement Therapy) products including nicotine nasal spray, nicotine inhaler, nicotine gum, transdermal nicotine patch and nicotine lozenge increased in demand among smokers after they were first approved for medicinal use in 1984. E-cigarettes are the dominant category of products in the global smoking cessation & nicotine de-addiction market. The growing adoption of these smoking cessation & nicotine de-addiction products is anticipated to further proliferate the market growth.
Rise in penetration of e-cigarettes across the globe is increasing the market size of global smoking cessation & nicotine de-addiction market and is expected to drive the market in future. Although the size of e-cigarettes market is minute, compared to global nicotine ecosystem, the global market share of e-cigarettes have increased from 1.5% in 2017 to 1.9% in 2018. The U.S. is the largest e-cigarettes market in the world. In the U.S., as per the 2019 National Youth Tobacco Survey conducted by FDA and CDC, the number of youths presently using e-cigarettes have increased from 3.6 Million plus in 2018 to 5.0 million plus in 2019. In 2016, in U.S., the market was dominated by both closed and open e-cigarettes. However, with passage of time, the market share of closed e-cigarettes system increased and in 2017, it held a major market share. Thus, rise in e-cigarettes consumption by youths in the U.S. is driving the growth of global smoking cessation & nicotine de-addiction market.
Asia Pacific region represents a good opportunity for growth of global smoking cessation & nicotine de-addiction market players. China represents the largest tobacco market in the world. Penetration of vaping or e-cigarettes is low compared to the U.S. and the U.K. China is also the dominant manufacturer of e-cigarettes in the world. Shenzen located in Southern China is home to more than thousand e-cigarettes equipment and component markers. As per Electronic Cigarette Industry Committee of China Electronics Chamber of Commerce, the market revenue for e-cigarette manufacturers in China have increased to US$ 4.8 Billion in 2018 with a y-o-y growth of 70.0%. As dominant portion of e-cigarettes are manufactured in China and there is low penetration of e-cigarettes among Chinese consumers, compared to Western countries which presents a good opportunity for growth of global e-cigarette market players s
Although NRT products are approved by government across the world for medication purpose to help smokers quit smoking, e-cigarettes face several regulatory restrictions. In the U.S. which is the largest e-cigarette market, in August 2016, the FDA (Food & Drug Administration) made it illegal to sell e-cigarettes or Electronic Nicotine Delivery System (ENDS) to people less than 18 years of age. Similarly, Asia Pacific countries, such as China and India, have already restricted access to e-cigarettes. Thus, significant regulatory pressure is being imposed, thereby limiting the expansion of smoking cessation & nicotine de-addiction market.
The report also includes trends in smoking cessation & nicotine de-addiction market in global, regional and country levels, Porter Five Force Analysis, Value Chain Analysis of global smoking cessation & nicotine de-addiction market from raw material suppliers, manufacturers till distribution channel, Key Market Indicators, global market outlook, Export Import data, country-wise smoking cessation & nicotine de-addiction brand analysis along with consumer behavior in each country. The report also include market attractiveness analysis in terms of market opportunity analysis and CAGR (Compounded Annual Growth Rate) at country level, regional level and global level.
Global Smoking Cessation & Nicotine De-addiction Market Revenue (US$ Million), 2015 – 2027
Competitive Landscape
The report provides both, qualitative and quantitative research of global smoking cessation & nicotine de-addiction market, as well as provides worthy insights into the rational scenario and favored development methods adopted by key contenders. The report also offers extensive research on the key players in global smoking cessation & nicotine de-addiction market and detailed insights on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their headquarters, competitors, product/service type, application and specification, pricing, and gross margin.
The primary market participants in the global smoking cessation & nicotine de-addiction market include Juul Labs, Inc., British American Tobacco Plc., Imperial Brands Plc., Japan Tobacco Inc., Altria Group, Inc., ShenZhen Joye Technology Co., Ltd., Shenzhen Kanger Technology Co., Ltd., GaiaTrend SARL, Twisp Pty Ltd., Shenzhen IVPS Technology Co. Ltd., Pfizer Inc., GlaxoSmithKline plc (GSK), Cipla Ltd., Johnson & Johnson (J&J), ITC Ltd., Takeda Pharmaceutical Company Ltd., Alkalon A/S, 22nd Century Group, Inc. among others.
Global Smoking Cessation & Nicotine De-addiction Market
- By Product Type
- With Nicotine
- OTC Products
- E-cigarettes
- Open System
- Closed System
- Nicotine Gums (NRT)
- Nicotine Patches (NRT)
- Nicotine Lozenges (NRT)
- Nicotine Tablets (NRT)
- E-cigarettes
- Prescription Products
- Nicotine Sprays (NRT)
- Nicotine Inhalers (NRT)
- OTC Products
- Without Nicotine
- OTC Products
- E-cigarettes
- Open System
- Closed System
- E-cigarettes
- Prescription Products
- Zyban
- Chantix
- OTC Products
- With Nicotine
- By Distribution Channel
- Online
- Offline
- Single-brand Vape Stores
- Multi-brand Vape Stores
- Retail Outlets
- By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The U.K
- Germany
- Spain
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2013 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Smoking Cessation and Nicotine
de-addiction Market
6. Market Synopsis:
Smoking Cessation and Nicotine de-addiction Market
7. Smoking Cessation and Nicotine de-addiction Market Analysis:
Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Smoking Cessation and Nicotine de-addiction Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Smoking Cessation and Nicotine de-addiction
Market
7.6. Porter’s
Five Force Analysis
7.7. PESTEL
Analysis
8. Global Smoking Cessation and Nicotine de-addiction Market
Analysis and Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global
Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn)
8.2. Global Smoking
Cessation and Nicotine de-addiction Market Revenue (US$ Mn) and Forecasts, By
Product Type
8.2.1. With
Nicotine (Definition, Market Estimation and Penetration, 2013 – 2018, Market
Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on OTC Products, Prescription
Products)
8.2.1.1. OTC Products
8.2.1.1.1. E-cigarettes
8.2.1.1.1.1. Open System
8.2.1.1.1.2. Closed System
8.2.1.1.2. Nicotine
Gums (NRT)
8.2.1.1.3. Nicotine
Patches (NRT)
8.2.1.1.4. Nicotine
Lozenges (NRT)
8.2.1.1.5. Nicotine
Tablets (NRT)
8.2.1.2. Prescription Products
8.2.1.2.1. Nicotine
Sprays (NRT)
8.2.1.2.2. Nicotine
Inhalers (NRT)
8.2.2. Without
Nicotine (Definition, Market Estimation and Penetration, 2013 – 2018, Market
Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on OTC Products, Prescription
Products)
8.2.2.1. OTC Products
8.2.2.1.1. E-cigarettes
8.2.2.1.1.1. Open System
8.2.2.1.1.2. Closed System
8.2.2.2. Prescription Products
8.2.2.2.1. Zyban
8.2.2.2.2. Chantix
8.3. Key
Segment for Channeling Investments
8.3.1. By
Product Type
9. Global Smoking Cessation and Nicotine de-addiction Market
Analysis and Forecasts, 2019 – 2027
9.1. Overview
9.2. Global
Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
9.2.1. Online
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2013 – 2018
9.2.1.3. Market Forecast, 2019 – 2027
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2013 – 2018
9.2.1.5.1.2. Market
Forecast, 2019 – 2027
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2013 – 2018
9.2.1.5.2.2. Market
Forecast, 2019 – 2027
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2013 – 2018
9.2.1.5.3.2. Market
Forecast, 2019 – 2027
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2013 – 2018
9.2.1.5.4.2. Market
Forecast, 2019 – 2027
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2013 – 2018
9.2.1.5.5.2. Market
Forecast, 2019 – 2027
9.2.2. Offline
(Definition, Market Estimation and Penetration, 2013 – 2018, Market Estimation
(2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Single-brand Vape Stores,
Multi-brand Vape Stores, Retail Stores)
9.2.2.1. Single-brand Vape Stores
9.2.2.2. Multi-brand Vape Stores
9.2.2.3. Retail Stores
9.3. Key
Segment for Channeling Investments
9.3.1. By
Distribution Channel
10. North America Smoking Cessation and Nicotine de-addiction
Market Analysis and Forecasts, 2019 - 2027
10.1. Overview
10.1.1. North
America Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn)
10.2. North
America Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn) and
Forecasts, By Product Type
10.2.1. With
Nicotine
10.2.1.1. OTC Products
10.2.1.1.1. E-cigarettes
10.2.1.1.1.1. Open System
10.2.1.1.1.2. Closed System
10.2.1.1.2. Nicotine
Gums (NRT)
10.2.1.1.3. Nicotine
Patches (NRT)
10.2.1.1.4. Nicotine
Lozenges (NRT)
10.2.1.1.5. Nicotine
Tablets (NRT)
10.2.1.2. Prescription Products
10.2.1.2.1. Nicotine
Sprays (NRT)
10.2.1.2.2. Nicotine
Inhalers (NRT)
10.2.2. Without
Nicotine
10.2.2.1. OTC Products
10.2.2.1.1. E-cigarettes
10.2.2.1.1.1. Open System
10.2.2.1.1.2. Closed
System
10.2.2.2. Prescription Products
10.2.2.2.1. Zyban
10.2.2.2.2. Chantix
10.3. North
America Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
10.3.1. Online
10.3.2. Offline
10.3.2.1. Single-brand Vape Stores
10.3.2.2. Multi-brand Vape Stores
10.3.2.3. Retail Stores
10.4. North
America Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn) and
Forecasts, By Country
10.4.1. U.S
10.4.1.1. U.S Smoking Cessation and Nicotine de-addiction Market Revenue
(US$ Mn) and Forecasts, By Product Type
10.4.1.1.1. With
Nicotine
10.4.1.1.1.1. OTC
Products
10.4.1.1.1.1.1. E-cigarettes
10.4.1.1.1.1.1.1. Open System
10.4.1.1.1.1.1.2. Closed System
10.4.1.1.1.1.2. Nicotine Gums (NRT)
10.4.1.1.1.1.3. Nicotine Patches (NRT)
10.4.1.1.1.1.4. Nicotine Lozenges (NRT)
10.4.1.1.1.1.5. Nicotine Tablets (NRT)
10.4.1.1.1.2. Prescription
Products
10.4.1.1.1.2.1. Nicotine Sprays (NRT)
10.4.1.1.1.2.2. Nicotine Inhalers (NRT)
10.4.1.1.2. Without
Nicotine
10.4.1.1.2.1. OTC
Products
10.4.1.1.2.1.1. E-cigarettes
10.4.1.1.2.1.1.1. Open System
10.4.1.1.2.1.1.2. Closed System
10.4.1.1.2.2. Prescription
Products
10.4.1.1.2.2.1. Zyban
10.4.1.1.2.2.2. Chantix
10.4.1.2. U.S Smoking Cessation and Nicotine de-addiction Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
10.4.1.2.1. Online
10.4.1.2.2. Offline
10.4.1.2.2.1. Single-brand
Vape Stores
10.4.1.2.2.2. Multi-brand
Vape Stores
10.4.1.2.2.3. Retail
Stores
10.4.2. Canada
10.4.2.1. Canada Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
10.4.2.1.1. With
Nicotine
10.4.2.1.1.1. OTC
Products
10.4.2.1.1.1.1. E-cigarettes
10.4.2.1.1.1.1.1. Open System
10.4.2.1.1.1.1.2. Closed System
10.4.2.1.1.1.2. Nicotine Gums (NRT)
10.4.2.1.1.1.3. Nicotine Patches (NRT)
10.4.2.1.1.1.4. Nicotine Lozenges (NRT)
10.4.2.1.1.1.5. Nicotine Tablets (NRT)
10.4.2.1.1.2. Prescription
Products
10.4.2.1.1.2.1. Nicotine Sprays (NRT)
10.4.2.1.1.2.2. Nicotine Inhalers (NRT)
10.4.2.1.2. Without
Nicotine
10.4.2.1.2.1. OTC
Products
10.4.2.1.2.1.1. E-cigarettes
10.4.2.1.2.1.1.1. Open System
10.4.2.1.2.1.1.2. Closed System
10.4.2.1.2.2. Prescription
Products
10.4.2.1.2.2.1. Zyban
10.4.2.1.2.2.2. Chantix
10.4.2.2. Canada Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
10.4.2.2.1. Online
10.4.2.2.2. Offline
10.4.2.2.2.1. Single-brand
Vape Stores
10.4.2.2.2.2. Multi-brand
Vape Stores
10.4.2.2.2.3. Retail
Stores
10.4.3. Mexico
10.4.3.1. Mexico Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
10.4.3.1.1. With
Nicotine
10.4.3.1.1.1. OTC
Products
10.4.3.1.1.1.1. E-cigarettes
10.4.3.1.1.1.1.1. Open System
10.4.3.1.1.1.1.2. Closed System
10.4.3.1.1.1.2. Nicotine Gums (NRT)
10.4.3.1.1.1.3. Nicotine Patches (NRT)
10.4.3.1.1.1.4. Nicotine Lozenges (NRT)
10.4.3.1.1.1.5. Nicotine Tablets (NRT)
10.4.3.1.1.2. Prescription
Products
10.4.3.1.1.2.1. Nicotine Sprays (NRT)
10.4.3.1.1.2.2. Nicotine Inhalers (NRT)
10.4.3.1.2. Without
Nicotine
10.4.3.1.2.1. OTC
Products
10.4.3.1.2.1.1. E-cigarettes
10.4.3.1.2.1.1.1. Open System
10.4.3.1.2.1.1.2. Closed System
10.4.3.1.2.2. Prescription
Products
10.4.3.1.2.2.1. Zyban
10.4.3.1.2.2.2. Chantix
10.4.3.2. Mexico Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
10.4.3.2.1. Online
10.4.3.2.2. Offline
10.4.3.2.2.1. Single-brand
Vape Stores
10.4.3.2.2.2. Multi-brand
Vape Stores
10.4.3.2.2.3. Retail
Stores
10.4.4. Rest of
North America
10.4.4.1. Rest of North America Smoking Cessation and Nicotine
de-addiction Market Revenue (US$ Mn) and Forecasts, By Product Type
10.4.4.1.1. With
Nicotine
10.4.4.1.1.1. OTC
Products
10.4.4.1.1.1.1. E-cigarettes
10.4.4.1.1.1.1.1. Open System
10.4.4.1.1.1.1.2. Closed System
10.4.4.1.1.1.2. Nicotine Gums (NRT)
10.4.4.1.1.1.3. Nicotine Patches (NRT)
10.4.4.1.1.1.4. Nicotine Lozenges (NRT)
10.4.4.1.1.1.5. Nicotine Tablets (NRT)
10.4.4.1.1.2. Prescription
Products
10.4.4.1.1.2.1. Nicotine Sprays (NRT)
10.4.4.1.1.2.2. Nicotine Inhalers (NRT)
10.4.4.1.2. Without
Nicotine
10.4.4.1.2.1. OTC
Products
10.4.4.1.2.1.1. E-cigarettes
10.4.4.1.2.1.1.1. Open System
10.4.4.1.2.1.1.2. Closed System
10.4.4.1.2.2. Prescription
Products
10.4.4.1.2.2.1. Zyban
10.4.4.1.2.2.2. Chantix
10.4.4.2. Rest of North America Smoking Cessation and Nicotine
de-addiction Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
10.4.4.2.1. Online
10.4.4.2.2. Offline
10.4.4.2.2.1. Single-brand
Vape Stores
10.4.4.2.2.2. Multi-brand
Vape Stores
10.4.4.2.2.3. Retail
Stores
10.5. Key
Segment for Channeling Investments
10.5.1. By
Country
10.5.2. By
Product Type
10.5.3. By
Distribution Channel
11. Europe Smoking Cessation and Nicotine de-addiction Market
Analysis and Forecasts, 2019 - 2027
11.1. Overview
11.1.1. Europe
Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn)
11.2. Europe
Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn) and
Forecasts, By Product Type
11.2.1. With
Nicotine
11.2.1.1. OTC Products
11.2.1.1.1. E-cigarettes
11.2.1.1.1.1. Open System
11.2.1.1.1.2. Closed System
11.2.1.1.2. Nicotine
Gums (NRT)
11.2.1.1.3. Nicotine
Patches (NRT)
11.2.1.1.4. Nicotine
Lozenges (NRT)
11.2.1.1.5. Nicotine
Tablets (NRT)
11.2.1.2. Prescription Products
11.2.1.2.1. Nicotine
Sprays (NRT)
11.2.1.2.2. Nicotine
Inhalers (NRT)
11.2.2. Without
Nicotine
11.2.2.1. OTC Products
11.2.2.1.1. E-cigarettes
11.2.2.1.1.1. Open System
11.2.2.1.1.2. Closed
System
11.2.2.2. Prescription Products
11.2.2.2.1. Zyban
11.2.2.2.2. Chantix
11.3. Europe
Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
11.3.1. Online
11.3.2. Offline
11.3.2.1. Single-brand Vape Stores
11.3.2.2. Multi-brand Vape Stores
11.3.2.3. Retail Stores
11.4. Europe
Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn) and
Forecasts, By Country
11.4.1. France
11.4.1.1. France Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
11.4.1.1.1. With
Nicotine
11.4.1.1.1.1. OTC
Products
11.4.1.1.1.1.1. E-cigarettes
11.4.1.1.1.1.1.1. Open System
11.4.1.1.1.1.1.2. Closed System
11.4.1.1.1.1.2. Nicotine Gums (NRT)
11.4.1.1.1.1.3. Nicotine Patches (NRT)
11.4.1.1.1.1.4. Nicotine Lozenges (NRT)
11.4.1.1.1.1.5. Nicotine Tablets (NRT)
11.4.1.1.1.2. Prescription
Products
11.4.1.1.1.2.1. Nicotine Sprays (NRT)
11.4.1.1.1.2.2. Nicotine Inhalers (NRT)
11.4.1.1.2. Without
Nicotine
11.4.1.1.2.1. OTC
Products
11.4.1.1.2.1.1. E-cigarettes
11.4.1.1.2.1.1.1. Open System
11.4.1.1.2.1.1.2. Closed System
11.4.1.1.2.2. Prescription
Products
11.4.1.1.2.2.1. Zyban
11.4.1.1.2.2.2. Chantix
11.4.1.2. France Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.4.1.2.1. Online
11.4.1.2.2. Offline
11.4.1.2.2.1. Single-brand
Vape Stores
11.4.1.2.2.2. Multi-brand
Vape Stores
11.4.1.2.2.3. Retail
Stores
11.4.2. The UK
11.4.2.1. The UK Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
11.4.2.1.1. With
Nicotine
11.4.2.1.1.1. OTC
Products
11.4.2.1.1.1.1. E-cigarettes
11.4.2.1.1.1.1.1. Open System
11.4.2.1.1.1.1.2. Closed System
11.4.2.1.1.1.2. Nicotine Gums (NRT)
11.4.2.1.1.1.3. Nicotine Patches (NRT)
11.4.2.1.1.1.4. Nicotine Lozenges (NRT)
11.4.2.1.1.1.5. Nicotine Tablets (NRT)
11.4.2.1.1.2. Prescription
Products
11.4.2.1.1.2.1. Nicotine Sprays (NRT)
11.4.2.1.1.2.2. Nicotine Inhalers (NRT)
11.4.2.1.2. Without
Nicotine
11.4.2.1.2.1. OTC
Products
11.4.2.1.2.1.1. E-cigarettes
11.4.2.1.2.1.1.1. Open System
11.4.2.1.2.1.1.2. Closed System
11.4.2.1.2.2. Prescription
Products
11.4.2.1.2.2.1. Zyban
11.4.2.1.2.2.2. Chantix
11.4.2.2. The UK Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.4.2.2.1. Online
11.4.2.2.2. Offline
11.4.2.2.2.1. Single-brand
Vape Stores
11.4.2.2.2.2. Multi-brand
Vape Stores
11.4.2.2.2.3. Retail
Stores
11.4.3. Spain
11.4.3.1. Spain Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
11.4.3.1.1. With
Nicotine
11.4.3.1.1.1. OTC
Products
11.4.3.1.1.1.1. E-cigarettes
11.4.3.1.1.1.1.1. Open System
11.4.3.1.1.1.1.2. Closed System
11.4.3.1.1.1.2. Nicotine Gums (NRT)
11.4.3.1.1.1.3. Nicotine Patches (NRT)
11.4.3.1.1.1.4. Nicotine Lozenges (NRT)
11.4.3.1.1.1.5. Nicotine Tablets (NRT)
11.4.3.1.1.2. Prescription
Products
11.4.3.1.1.2.1. Nicotine Sprays (NRT)
11.4.3.1.1.2.2. Nicotine Inhalers (NRT)
11.4.3.1.2. Without
Nicotine
11.4.3.1.2.1. OTC
Products
11.4.3.1.2.1.1. E-cigarettes
11.4.3.1.2.1.1.1. Open System
11.4.3.1.2.1.1.2. Closed System
11.4.3.1.2.2. Prescription
Products
11.4.3.1.2.2.1. Zyban
11.4.3.1.2.2.2. Chantix
11.4.3.2. Spain Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.4.3.2.1. Online
11.4.3.2.2. Offline
11.4.3.2.2.1. Single-brand
Vape Stores
11.4.3.2.2.2. Multi-brand
Vape Stores
11.4.3.2.2.3. Retail
Stores
11.4.4. Germany
11.4.4.1. Germany Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
11.4.4.1.1. With
Nicotine
11.4.4.1.1.1. OTC
Products
11.4.4.1.1.1.1. E-cigarettes
11.4.4.1.1.1.1.1. Open System
11.4.4.1.1.1.1.2. Closed System
11.4.4.1.1.1.2. Nicotine Gums (NRT)
11.4.4.1.1.1.3. Nicotine Patches (NRT)
11.4.4.1.1.1.4. Nicotine Lozenges (NRT)
11.4.4.1.1.1.5. Nicotine Tablets (NRT)
11.4.4.1.1.2. Prescription
Products
11.4.4.1.1.2.1. Nicotine Sprays (NRT)
11.4.4.1.1.2.2. Nicotine Inhalers (NRT)
11.4.4.1.2. Without
Nicotine
11.4.4.1.2.1. OTC
Products
11.4.4.1.2.1.1. E-cigarettes
11.4.4.1.2.1.1.1. Open System
11.4.4.1.2.1.1.2. Closed System
11.4.4.1.2.2. Prescription
Products
11.4.4.1.2.2.1. Zyban
11.4.4.1.2.2.2. Chantix
11.4.4.2. Germany Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.4.4.2.1. Online
11.4.4.2.2. Offline
11.4.4.2.2.1. Single-brand
Vape Stores
11.4.4.2.2.2. Multi-brand
Vape Stores
11.4.4.2.2.3. Retail
Stores
11.4.5. Italy
11.4.5.1. Italy Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
11.4.5.1.1. With
Nicotine
11.4.5.1.1.1. OTC
Products
11.4.5.1.1.1.1. E-cigarettes
11.4.5.1.1.1.1.1. Open System
11.4.5.1.1.1.1.2. Closed System
11.4.5.1.1.1.2. Nicotine Gums (NRT)
11.4.5.1.1.1.3. Nicotine Patches (NRT)
11.4.5.1.1.1.4. Nicotine Lozenges (NRT)
11.4.5.1.1.1.5. Nicotine Tablets (NRT)
11.4.5.1.1.2. Prescription
Products
11.4.5.1.1.2.1. Nicotine Sprays (NRT)
11.4.5.1.1.2.2. Nicotine Inhalers (NRT)
11.4.5.1.2. Without
Nicotine
11.4.5.1.2.1. OTC
Products
11.4.5.1.2.1.1. E-cigarettes
11.4.5.1.2.1.1.1. Open System
11.4.5.1.2.1.1.2. Closed System
11.4.5.1.2.2. Prescription
Products
11.4.5.1.2.2.1. Zyban
11.4.5.1.2.2.2. Chantix
11.4.5.2. Italy Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.4.5.2.1. Online
11.4.5.2.2. Offline
11.4.5.2.2.1. Single-brand
Vape Stores
11.4.5.2.2.2. Multi-brand
Vape Stores
11.4.5.2.2.3. Retail
Stores
11.4.6. Nordic
Countries
11.4.6.1. Nordic Countries Smoking Cessation and Nicotine de-addiction
Market Revenue (US$ Mn) and Forecasts, By Product Type
11.4.6.1.1. With
Nicotine
11.4.6.1.1.1. OTC
Products
11.4.6.1.1.1.1. E-cigarettes
11.4.6.1.1.1.1.1. Open System
11.4.6.1.1.1.1.2. Closed System
11.4.6.1.1.1.2. Nicotine Gums (NRT)
11.4.6.1.1.1.3. Nicotine Patches (NRT)
11.4.6.1.1.1.4. Nicotine Lozenges (NRT)
11.4.6.1.1.1.5. Nicotine Tablets (NRT)
11.4.6.1.1.2. Prescription
Products
11.4.6.1.1.2.1. Nicotine Sprays (NRT)
11.4.6.1.1.2.2. Nicotine Inhalers (NRT)
11.4.6.1.2. Without
Nicotine
11.4.6.1.2.1. OTC
Products
11.4.6.1.2.1.1. E-cigarettes
11.4.6.1.2.1.1.1. Open System
11.4.6.1.2.1.1.2. Closed System
11.4.6.1.2.2. Prescription
Products
11.4.6.1.2.2.1. Zyban
11.4.6.1.2.2.2. Chantix
11.4.6.2. Nordic Countries Smoking Cessation and Nicotine de-addiction
Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.4.6.2.1. Online
11.4.6.2.2. Offline
11.4.6.2.2.1. Single-brand
Vape Stores
11.4.6.2.2.2. Multi-brand
Vape Stores
11.4.6.2.2.3. Retail
Stores
11.4.6.3. Nordic Countries Smoking Cessation and Nicotine de-addiction
Market Revenue (US$ Mn) and Forecasts, By Country
11.4.6.3.1. Denmark
11.4.6.3.2. Finland
11.4.6.3.3. Iceland
11.4.6.3.4. Sweden
11.4.6.3.5. Norway
11.4.7. Benelux
Union
11.4.7.1. Benelux Union Smoking Cessation and Nicotine de-addiction
Market Revenue (US$ Mn) and Forecasts, By Product Type
11.4.7.1.1. With
Nicotine
11.4.7.1.1.1. OTC
Products
11.4.7.1.1.1.1. E-cigarettes
11.4.7.1.1.1.1.1. Open System
11.4.7.1.1.1.1.2. Closed System
11.4.7.1.1.1.2. Nicotine Gums (NRT)
11.4.7.1.1.1.3. Nicotine Patches (NRT)
11.4.7.1.1.1.4. Nicotine Lozenges (NRT)
11.4.7.1.1.1.5. Nicotine Tablets (NRT)
11.4.7.1.1.2. Prescription
Products
11.4.7.1.1.2.1. Nicotine Sprays (NRT)
11.4.7.1.1.2.2. Nicotine Inhalers (NRT)
11.4.7.1.2. Without
Nicotine
11.4.7.1.2.1. OTC
Products
11.4.7.1.2.1.1. E-cigarettes
11.4.7.1.2.1.1.1. Open System
11.4.7.1.2.1.1.2. Closed System
11.4.7.1.2.2. Prescription
Products
11.4.7.1.2.2.1. Zyban
11.4.7.1.2.2.2. Chantix
11.4.7.2. Benelux Union Smoking Cessation and Nicotine de-addiction
Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.4.7.2.1. Online
11.4.7.2.2. Offline
11.4.7.2.2.1. Single-brand
Vape Stores
11.4.7.2.2.2. Multi-brand
Vape Stores
11.4.7.2.2.3. Retail
Stores
11.4.7.3. Benelux Union Smoking Cessation and Nicotine de-addiction
Market Revenue (US$ Mn) and Forecasts, By Country
11.4.7.3.1. Belgium
11.4.7.3.2. The
Netherlands
11.4.7.3.3. Luxembourg
11.4.8. Rest of
Europe
11.4.8.1. Rest of Europe Smoking Cessation and Nicotine de-addiction
Market Revenue (US$ Mn) and Forecasts, By Product Type
11.4.8.1.1. With
Nicotine
11.4.8.1.1.1. OTC
Products
11.4.8.1.1.1.1. E-cigarettes
11.4.8.1.1.1.1.1. Open System
11.4.8.1.1.1.1.2. Closed System
11.4.8.1.1.1.2. Nicotine Gums (NRT)
11.4.8.1.1.1.3. Nicotine Patches (NRT)
11.4.8.1.1.1.4. Nicotine Lozenges (NRT)
11.4.8.1.1.1.5. Nicotine Tablets (NRT)
11.4.8.1.1.2. Prescription
Products
11.4.8.1.1.2.1. Nicotine Sprays (NRT)
11.4.8.1.1.2.2. Nicotine Inhalers (NRT)
11.4.8.1.2. Without
Nicotine
11.4.8.1.2.1. OTC
Products
11.4.8.1.2.1.1. E-cigarettes
11.4.8.1.2.2. Prescription
Products
11.4.8.1.2.2.1. Zyban
11.4.8.1.2.2.2. Chantix
11.4.8.2. Rest of Europe Smoking Cessation and Nicotine de-addiction
Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.4.8.2.1. Online
11.4.8.2.2. Offline
11.4.8.2.2.1. Single-brand
Vape Stores
11.4.8.2.2.2. Multi-brand
Vape Stores
11.4.8.2.2.3. Retail
Stores
11.5. Key
Segment for Channeling Investments
11.5.1. By
Country
11.5.2. By
Product Type
11.5.3. By
Distribution Channel
12. Asia Pacific Smoking Cessation and Nicotine de-addiction
Market Analysis and Forecasts, 2019 - 2027
12.1. Overview
12.1.1. Asia Pacific
Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn)
12.2. Asia
Pacific Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn) and
Forecasts, By Product Type
12.2.1. With
Nicotine
12.2.1.1. OTC Products
12.2.1.1.1. E-cigarettes
12.2.1.1.1.1. Open System
12.2.1.1.1.2. Closed System
12.2.1.1.2. Nicotine
Gums (NRT)
12.2.1.1.3. Nicotine
Patches (NRT)
12.2.1.1.4. Nicotine
Lozenges (NRT)
12.2.1.1.5. Nicotine
Tablets (NRT)
12.2.1.2. Prescription Products
12.2.1.2.1. Nicotine
Sprays (NRT)
12.2.1.2.2. Nicotine
Inhalers (NRT)
12.2.2. Without
Nicotine
12.2.2.1. OTC Products
12.2.2.1.1. E-cigarettes
12.2.2.1.1.1. Open System
12.2.2.1.1.2. Closed System
12.2.2.2. Prescription Products
12.2.2.2.1. Zyban
12.2.2.2.2. Chantix
12.3. Asia
Pacific Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
12.3.1. Online
12.3.2. Offline
12.3.2.1. Single-brand Vape Stores
12.3.2.2. Multi-brand Vape Stores
12.3.2.3. Retail Stores
12.4. Asia
Pacific Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn) and
Forecasts, By Country
12.4.1. China
12.4.1.1. China Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
12.4.1.1.1. With
Nicotine
12.4.1.1.1.1. OTC
Products
12.4.1.1.1.1.1. E-cigarettes
12.4.1.1.1.1.1.1. Open System
12.4.1.1.1.1.1.2. Closed System
12.4.1.1.1.1.2. Nicotine Gums (NRT)
12.4.1.1.1.1.3. Nicotine Patches (NRT)
12.4.1.1.1.1.4. Nicotine Lozenges (NRT)
12.4.1.1.1.1.5. Nicotine Tablets (NRT)
12.4.1.1.1.2. Prescription
Products
12.4.1.1.1.2.1. Nicotine Sprays (NRT)
12.4.1.1.1.2.2. Nicotine Inhalers (NRT)
12.4.1.1.2. Without
Nicotine
12.4.1.1.2.1. OTC
Products
12.4.1.1.2.1.1. E-cigarettes
12.4.1.1.2.1.1.1. Open System
12.4.1.1.2.1.1.2. Closed System
12.4.1.1.2.2. Prescription
Products
12.4.1.1.2.2.1. Zyban
12.4.1.1.2.2.2. Chantix
12.4.1.2. China Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.4.1.2.1. Online
12.4.1.2.2. Offline
12.4.1.2.2.1. Single-brand
Vape Stores
12.4.1.2.2.2. Multi-brand
Vape Stores
12.4.1.2.2.3. Retail
Stores
12.4.2. Japan
12.4.2.1. Japan Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
12.4.2.1.1. With
Nicotine
12.4.2.1.1.1. OTC
Products
12.4.2.1.1.1.1. E-cigarettes
12.4.2.1.1.1.1.1. Open System
12.4.2.1.1.1.1.2. Closed System
12.4.2.1.1.1.2. Nicotine Gums (NRT)
12.4.2.1.1.1.3. Nicotine Patches (NRT)
12.4.2.1.1.1.4. Nicotine Lozenges (NRT)
12.4.2.1.1.1.5. Nicotine Tablets (NRT)
12.4.2.1.1.2. Prescription
Products
12.4.2.1.1.2.1. Nicotine Sprays (NRT)
12.4.2.1.1.2.2. Nicotine Inhalers (NRT)
12.4.2.1.2. Without
Nicotine
12.4.2.1.2.1. OTC
Products
12.4.2.1.2.1.1. E-cigarettes
12.4.2.1.2.1.1.1. Open System
12.4.2.1.2.1.1.2. Closed System
12.4.2.1.2.2. Prescription
Products
12.4.2.1.2.2.1. Zyban
12.4.2.1.2.2.2. Chantix
12.4.2.2. Japan Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.4.2.2.1. Online
12.4.2.2.2. Offline
12.4.2.2.2.1. Single-brand
Vape Stores
12.4.2.2.2.2. Multi-brand
Vape Stores
12.4.2.2.2.3. Retail
Stores
12.4.3. India
12.4.3.1. India Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
12.4.3.1.1. With
Nicotine
12.4.3.1.1.1. OTC
Products
12.4.3.1.1.1.1. E-cigarettes
12.4.3.1.1.1.1.1. Open System
12.4.3.1.1.1.1.2. Closed System
12.4.3.1.1.1.2. Nicotine Gums (NRT)
12.4.3.1.1.1.3. Nicotine Patches (NRT)
12.4.3.1.1.1.4. Nicotine Lozenges (NRT)
12.4.3.1.1.1.5. Nicotine Tablets (NRT)
12.4.3.1.1.2. Prescription
Products
12.4.3.1.1.2.1. Nicotine Sprays (NRT)
12.4.3.1.1.2.2. Nicotine Inhalers (NRT)
12.4.3.1.2. Without
Nicotine
12.4.3.1.2.1. OTC
Products
12.4.3.1.2.1.1. E-cigarettes
12.4.3.1.2.1.1.1. Open System
12.4.3.1.2.1.1.2. Closed System
12.4.3.1.2.2. Prescription
Products
12.4.3.1.2.2.1. Zyban
12.4.3.1.2.2.2. Chantix
12.4.3.2. India Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.4.3.2.1. Online
12.4.3.2.2. Offline
12.4.3.2.2.1. Single-brand
Vape Stores
12.4.3.2.2.2. Multi-brand
Vape Stores
12.4.3.2.2.3. Retail
Stores
12.4.4. New
Zealand
12.4.4.1. New Zealand Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
12.4.4.1.1. With
Nicotine
12.4.4.1.1.1. OTC
Products
12.4.4.1.1.1.1. E-cigarettes
12.4.4.1.1.1.1.1. Open System
12.4.4.1.1.1.1.2. Closed System
12.4.4.1.1.1.2. Nicotine Gums (NRT)
12.4.4.1.1.1.3. Nicotine Patches (NRT)
12.4.4.1.1.1.4. Nicotine Lozenges (NRT)
12.4.4.1.1.1.5. Nicotine Tablets (NRT)
12.4.4.1.1.2. Prescription
Products
12.4.4.1.1.2.1. Nicotine Sprays (NRT)
12.4.4.1.1.2.2. Nicotine Inhalers (NRT)
12.4.4.1.2. Without
Nicotine
12.4.4.1.2.1. OTC
Products
12.4.4.1.2.1.1. E-cigarettes
12.4.4.1.2.1.1.1. Open System
12.4.4.1.2.1.1.2. Closed System
12.4.4.1.2.2. Prescription
Products
12.4.4.1.2.2.1. Zyban
12.4.4.1.2.2.2. Chantix
12.4.4.2. New Zealand Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.4.4.2.1. Online
12.4.4.2.2. Offline
12.4.4.2.2.1. Single-brand
Vape Stores
12.4.4.2.2.2. Multi-brand
Vape Stores
12.4.4.2.2.3. Retail
Stores
12.4.5. Australia
12.4.5.1. Australia Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
12.4.5.1.1. With
Nicotine
12.4.5.1.1.1. OTC
Products
12.4.5.1.1.1.1. E-cigarettes
12.4.5.1.1.1.1.1. Open System
12.4.5.1.1.1.1.2. Closed System
12.4.5.1.1.1.2. Nicotine Gums (NRT)
12.4.5.1.1.1.3. Nicotine Patches (NRT)
12.4.5.1.1.1.4. Nicotine Lozenges (NRT)
12.4.5.1.1.1.5. Nicotine Tablets (NRT)
12.4.5.1.1.2. Prescription
Products
12.4.5.1.1.2.1. Nicotine Sprays (NRT)
12.4.5.1.1.2.2. Nicotine Inhalers (NRT)
12.4.5.1.2. Without
Nicotine
12.4.5.1.2.1. OTC
Products
12.4.5.1.2.1.1. E-cigarettes
12.4.5.1.2.1.1.1. Open System
12.4.5.1.2.1.1.2. Closed System
12.4.5.1.2.2. Prescription
Products
12.4.5.1.2.2.1. Zyban
12.4.5.1.2.2.2. Chantix
12.4.5.2. Australia Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.4.5.2.1. Online
12.4.5.2.2. Offline
12.4.5.2.2.1. Single-brand
Vape Stores
12.4.5.2.2.2. Multi-brand
Vape Stores
12.4.5.2.2.3. Retail
Stores
12.4.6. South
Korea
12.4.6.1. South Korea Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
12.4.6.1.1. With
Nicotine
12.4.6.1.1.1. OTC
Products
12.4.6.1.1.1.1. E-cigarettes
12.4.6.1.1.1.1.1. Open System
12.4.6.1.1.1.1.2. Closed System
12.4.6.1.1.1.2. Nicotine Gums (NRT)
12.4.6.1.1.1.3. Nicotine Patches (NRT)
12.4.6.1.1.1.4. Nicotine Lozenges (NRT)
12.4.6.1.1.1.5. Nicotine Tablets (NRT)
12.4.6.1.1.2. Prescription
Products
12.4.6.1.1.2.1. Nicotine Sprays (NRT)
12.4.6.1.1.2.2. Nicotine Inhalers (NRT)
12.4.6.1.2. Without
Nicotine
12.4.6.1.2.1. OTC
Products
12.4.6.1.2.1.1. E-cigarettes
12.4.6.1.2.1.1.1. Open System
12.4.6.1.2.1.1.2. Closed System
12.4.6.1.2.2. Prescription
Products
12.4.6.1.2.2.1. Zyban
12.4.6.1.2.2.2. Chantix
12.4.6.2. South Korea Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.4.6.2.1. Online
12.4.6.2.2. Offline
12.4.6.2.2.1. Single-brand
Vape Stores
12.4.6.2.2.2. Multi-brand
Vape Stores
12.4.6.2.2.3. Retail
Stores
12.4.7. Southeast
Asia
12.4.7.1. Southeast Asia Smoking Cessation and Nicotine de-addiction
Market Revenue (US$ Mn) and Forecasts, By Product Type
12.4.7.1.1. With
Nicotine
12.4.7.1.1.1. OTC
Products
12.4.7.1.1.1.1. E-cigarettes
12.4.7.1.1.1.1.1. Open System
12.4.7.1.1.1.1.2. Closed System
12.4.7.1.1.1.2. Nicotine Gums (NRT)
12.4.7.1.1.1.3. Nicotine Patches (NRT)
12.4.7.1.1.1.4. Nicotine Lozenges (NRT)
12.4.7.1.1.1.5. Nicotine Tablets (NRT)
12.4.7.1.1.2. Prescription
Products
12.4.7.1.1.2.1. Nicotine Sprays (NRT)
12.4.7.1.1.2.2. Nicotine Inhalers (NRT)
12.4.7.1.2. Without
Nicotine
12.4.7.1.2.1. OTC
Products
12.4.7.1.2.1.1. E-cigarettes
12.4.7.1.2.1.1.1. Open System
12.4.7.1.2.1.1.2. Closed System
12.4.7.1.2.2. Prescription
Products
12.4.7.1.2.2.1. Zyban
12.4.7.1.2.2.2. Chantix
12.4.7.2. Southeast Asia Smoking Cessation and Nicotine de-addiction
Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.4.7.2.1. Online
12.4.7.2.2. Offline
12.4.7.2.2.1. Single-brand
Vape Stores
12.4.7.2.2.2. Multi-brand
Vape Stores
12.4.7.2.2.3. Retail
Stores
12.4.7.3. Southeast Asia Smoking Cessation and Nicotine de-addiction
Market Revenue (US$ Mn) and Forecasts, By Country
12.4.7.3.1. Indonesia
12.4.7.3.2. Thailand
12.4.7.3.3. Malaysia
12.4.7.3.4. Singapore
12.4.7.3.5. Rest
of Southeast Asia
12.4.8. Rest of
Asia Pacific
12.4.8.1. Rest of Asia Pacific Smoking Cessation and Nicotine
de-addiction Market Revenue (US$ Mn) and Forecasts, By Product Type
12.4.8.1.1. With
Nicotine
12.4.8.1.1.1. OTC
Products
12.4.8.1.1.1.1. E-cigarettes
12.4.8.1.1.1.1.1. Open System
12.4.8.1.1.1.1.2. Closed System
12.4.8.1.1.1.2. Nicotine Gums (NRT)
12.4.8.1.1.1.3. Nicotine Patches (NRT)
12.4.8.1.1.1.4. Nicotine Lozenges (NRT)
12.4.8.1.1.1.5. Nicotine Tablets (NRT)
12.4.8.1.1.2. Prescription
Products
12.4.8.1.1.2.1. Nicotine Sprays (NRT)
12.4.8.1.1.2.2. Nicotine Inhalers (NRT)
12.4.8.1.2. Without
Nicotine
12.4.8.1.2.1. OTC
Products
12.4.8.1.2.1.1. E-cigarettes
12.4.8.1.2.1.1.1. Open System
12.4.8.1.2.1.1.2. Closed System
12.4.8.1.2.2. Prescription
Products
12.4.8.1.2.2.1. Zyban
12.4.8.1.2.2.2. Chantix
12.4.8.2. Rest of Asia Pacific Smoking Cessation and Nicotine
de-addiction Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.4.8.2.1. Online
12.4.8.2.2. Offline
12.4.8.2.2.1. Single-brand
Vape Stores
12.4.8.2.2.2. Multi-brand
Vape Stores
12.4.8.2.2.3. Retail
Stores
12.5. Key
Segment for Channeling Investments
12.5.1. By
Country
12.5.2. By
Product Type
12.5.3. By
Distribution Channel
13. Middle East and Africa Smoking Cessation and Nicotine
de-addiction Market Analysis and Forecasts, 2019 - 2027
13.1. Overview
13.1.1. Middle
East and Africa Smoking Cessation and Nicotine de-addiction Market Revenue (US$
Mn)
13.2. Middle
East and Africa Smoking Cessation and Nicotine de-addiction Market Revenue (US$
Mn) and Forecasts, By Product Type
13.2.1. With
Nicotine
13.2.1.1. OTC Products
13.2.1.1.1. E-cigarettes
13.2.1.1.1.1. Open System
13.2.1.1.1.2. Closed System
13.2.1.1.2. Nicotine
Gums (NRT)
13.2.1.1.3. Nicotine
Patches (NRT)
13.2.1.1.4. Nicotine
Lozenges (NRT)
13.2.1.1.5. Nicotine
Tablets (NRT)
13.2.1.2. Prescription Products
13.2.1.2.1. Nicotine
Sprays (NRT)
13.2.1.2.2. Nicotine
Inhalers (NRT)
13.2.2. Without
Nicotine
13.2.2.1. OTC Products
13.2.2.1.1. E-cigarettes
13.2.2.1.1.1. Open System
13.2.2.1.1.2. Closed System
13.2.2.2. Prescription Products
13.2.2.2.1. Zyban
13.2.2.2.2. Chantix
13.3. Middle
East and Africa Smoking Cessation and Nicotine de-addiction Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
13.3.1. Online
13.3.2. Offline
13.3.2.1. Single-brand Vape Stores
13.3.2.2. Multi-brand Vape Stores
13.3.2.3. Retail Stores
13.4. Middle
East and Africa Smoking Cessation and Nicotine de-addiction Market Revenue (US$
Mn) and Forecasts, By Country
13.4.1. Saudi
Arabia
13.4.1.1. Saudi Arabia Smoking Cessation and Nicotine de-addiction
Market Revenue (US$ Mn) and Forecasts, By Product Type
13.4.1.1.1. With
Nicotine
13.4.1.1.1.1. OTC
Products
13.4.1.1.1.1.1. E-cigarettes
13.4.1.1.1.1.1.1. Open System
13.4.1.1.1.1.1.2. Closed System
13.4.1.1.1.1.2. Nicotine Gums (NRT)
13.4.1.1.1.1.3. Nicotine Patches (NRT)
13.4.1.1.1.1.4. Nicotine Lozenges (NRT)
13.4.1.1.1.1.5. Nicotine Tablets (NRT)
13.4.1.1.1.2. Prescription
Products
13.4.1.1.1.2.1. Nicotine Sprays (NRT)
13.4.1.1.1.2.2. Nicotine Inhalers (NRT)
13.4.1.1.2. Without
Nicotine
13.4.1.1.2.1. OTC
Products
13.4.1.1.2.1.1. E-cigarettes
13.4.1.1.2.1.1.1. Open System
13.4.1.1.2.1.1.2. Closed System
13.4.1.1.2.2. Prescription
Products
13.4.1.1.2.2.1. Zyban
13.4.1.1.2.2.2. Chantix
13.4.1.2. Saudi Arabia Smoking Cessation and Nicotine de-addiction
Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.4.1.2.1. Online
13.4.1.2.2. Offline
13.4.1.2.2.1. Single-brand
Vape Stores
13.4.1.2.2.2. Multi-brand
Vape Stores
13.4.1.2.2.3. Retail
Stores
13.4.2. UAE
13.4.2.1. UAE Smoking Cessation and Nicotine de-addiction Market Revenue
(US$ Mn) and Forecasts, By Product Type
13.4.2.1.1. With
Nicotine
13.4.2.1.1.1. OTC
Products
13.4.2.1.1.1.1. E-cigarettes
13.4.2.1.1.1.1.1. Open System
13.4.2.1.1.1.1.2. Closed System
13.4.2.1.1.1.2. Nicotine Gums (NRT)
13.4.2.1.1.1.3. Nicotine Patches (NRT)
13.4.2.1.1.1.4. Nicotine Lozenges (NRT)
13.4.2.1.1.1.5. Nicotine Tablets (NRT)
13.4.2.1.1.2. Prescription
Products
13.4.2.1.1.2.1. Nicotine Sprays (NRT)
13.4.2.1.1.2.2. Nicotine Inhalers (NRT)
13.4.2.1.2. Without
Nicotine
13.4.2.1.2.1. OTC
Products
13.4.2.1.2.1.1. E-cigarettes
13.4.2.1.2.1.1.1. Open System
13.4.2.1.2.1.1.2. Closed System
13.4.2.1.2.2. Prescription
Products
13.4.2.1.2.2.1. Zyban
13.4.2.1.2.2.2. Chantix
13.4.2.2. UAE Smoking Cessation and Nicotine de-addiction Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
13.4.2.2.1. Online
13.4.2.2.2. Offline
13.4.2.2.2.1. Single-brand
Vape Stores
13.4.2.2.2.2. Multi-brand
Vape Stores
13.4.2.2.2.3. Retail
Stores
13.4.3. Egypt
13.4.3.1. Egypt Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
13.4.3.1.1. With
Nicotine
13.4.3.1.1.1. OTC
Products
13.4.3.1.1.1.1. E-cigarettes
13.4.3.1.1.1.1.1. Open System
13.4.3.1.1.1.1.2. Closed System
13.4.3.1.1.1.2. Nicotine Gums (NRT)
13.4.3.1.1.1.3. Nicotine Patches (NRT)
13.4.3.1.1.1.4. Nicotine Lozenges (NRT)
13.4.3.1.1.1.5. Nicotine Tablets (NRT)
13.4.3.1.1.2. Prescription
Products
13.4.3.1.1.2.1. Nicotine Sprays (NRT)
13.4.3.1.1.2.2. Nicotine Inhalers (NRT)
13.4.3.1.2. Without
Nicotine
13.4.3.1.2.1. OTC
Products
13.4.3.1.2.1.1. E-cigarettes
13.4.3.1.2.1.1.1. Open System
13.4.3.1.2.1.1.2. Closed System
13.4.3.1.2.2. Prescription
Products
13.4.3.1.2.2.1. Zyban
13.4.3.1.2.2.2. Chantix
13.4.3.2. Egypt Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.4.3.2.1. Online
13.4.3.2.2. Offline
13.4.3.2.2.1. Single-brand
Vape Stores
13.4.3.2.2.2. Multi-brand
Vape Stores
13.4.3.2.2.3. Retail
Stores
13.4.4. Kuwait
13.4.4.1. Kuwait Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
13.4.4.1.1. With
Nicotine
13.4.4.1.1.1. OTC
Products
13.4.4.1.1.1.1. E-cigarettes
13.4.4.1.1.1.1.1. Open System
13.4.4.1.1.1.1.2. Closed System
13.4.4.1.1.1.2. Nicotine Gums (NRT)
13.4.4.1.1.1.3. Nicotine Patches (NRT)
13.4.4.1.1.1.4. Nicotine Lozenges (NRT)
13.4.4.1.1.1.5. Nicotine Tablets (NRT)
13.4.4.1.1.2. Prescription
Products
13.4.4.1.1.2.1. Nicotine Sprays (NRT)
13.4.4.1.1.2.2. Nicotine Inhalers (NRT)
13.4.4.1.2. Without
Nicotine
13.4.4.1.2.1. OTC
Products
13.4.4.1.2.1.1. E-cigarettes
13.4.4.1.2.1.1.1. Open System
13.4.4.1.2.1.1.2. Closed System
13.4.4.1.2.2. Prescription
Products
13.4.4.1.2.2.1. Zyban
13.4.4.1.2.2.2. Chantix
13.4.4.2. Kuwait Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.4.4.2.1. Online
13.4.4.2.2. Offline
13.4.4.2.2.1. Single-brand
Vape Stores
13.4.4.2.2.2. Multi-brand
Vape Stores
13.4.4.2.2.3. Retail
Stores
13.4.5. South
Africa
13.4.5.1. South Africa Smoking Cessation and Nicotine de-addiction
Market Revenue (US$ Mn) and Forecasts, By Product Type
13.4.5.1.1. With
Nicotine
13.4.5.1.1.1. OTC
Products
13.4.5.1.1.1.1. E-cigarettes
13.4.5.1.1.1.1.1. Open System
13.4.5.1.1.1.1.2. Closed System
13.4.5.1.1.1.2. Nicotine Gums (NRT)
13.4.5.1.1.1.3. Nicotine Patches (NRT)
13.4.5.1.1.1.4. Nicotine Lozenges (NRT)
13.4.5.1.1.1.5. Nicotine Tablets (NRT)
13.4.5.1.1.2. Prescription
Products
13.4.5.1.1.2.1. Nicotine Sprays (NRT)
13.4.5.1.1.2.2. Nicotine Inhalers (NRT)
13.4.5.1.2. Without
Nicotine
13.4.5.1.2.1. OTC
Products
13.4.5.1.2.1.1. E-cigarettes
13.4.5.1.2.1.1.1. Open System
13.4.5.1.2.1.1.2. Closed System
13.4.5.1.2.2. Prescription
Products
13.4.5.1.2.2.1. Zyban
13.4.5.1.2.2.2. Chantix
13.4.5.2. South Africa Smoking Cessation and Nicotine de-addiction
Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.4.5.2.1. Online
13.4.5.2.2. Offline
13.4.5.2.2.1. Single-brand
Vape Stores
13.4.5.2.2.2. Multi-brand
Vape Stores
13.4.5.2.2.3. Retail
Stores
13.4.6. Rest of
Middle East & Africa
13.4.6.1. Rest of Middle East & Africa Smoking Cessation and
Nicotine de-addiction Market Revenue (US$ Mn) and Forecasts, By Product Type
13.4.6.1.1. With
Nicotine
13.4.6.1.1.1. OTC
Products
13.4.6.1.1.1.1. E-cigarettes
13.4.6.1.1.1.1.1. Open System
13.4.6.1.1.1.1.2. Closed System
13.4.6.1.1.1.2. Nicotine Gums (NRT)
13.4.6.1.1.1.3. Nicotine Patches (NRT)
13.4.6.1.1.1.4. Nicotine Lozenges (NRT)
13.4.6.1.1.1.5. Nicotine Tablets (NRT)
13.4.6.1.1.2. Prescription
Products
13.4.6.1.1.2.1. Nicotine Sprays (NRT)
13.4.6.1.1.2.2. Nicotine Inhalers (NRT)
13.4.6.1.2. Without
Nicotine
13.4.6.1.2.1. OTC
Products
13.4.6.1.2.1.1. E-cigarettes
13.4.6.1.2.1.1.1. Open System
13.4.6.1.2.1.1.2. Closed System
13.4.6.1.2.2. Prescription
Products
13.4.6.1.2.2.1. Zyban
13.4.6.1.2.2.2. Chantix
13.4.6.2. Rest of Middle East & Africa Smoking Cessation and
Nicotine de-addiction Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.4.6.2.1. Online
13.4.6.2.2. Offline
13.4.6.2.2.1. Single-brand
Vape Stores
13.4.6.2.2.2. Multi-brand
Vape Stores
13.4.6.2.2.3. Retail
Stores
13.5. Key
Segment for Channeling Investments
13.5.1. By
Country
13.5.2. By
Product Type
13.5.3. By
Distribution Channel
14. Latin America Smoking Cessation and Nicotine de-addiction
Market Analysis and Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Latin
America Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn)
14.2. Latin
America Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn) and
Forecasts, By Product Type
14.2.1. With
Nicotine
14.2.1.1. OTC Products
14.2.1.1.1. E-cigarettes
14.2.1.1.1.1. Open System
14.2.1.1.1.2. Closed System
14.2.1.1.2. Nicotine
Gums (NRT)
14.2.1.1.3. Nicotine
Patches (NRT)
14.2.1.1.4. Nicotine
Lozenges (NRT)
14.2.1.1.5. Nicotine
Tablets (NRT)
14.2.1.2. Prescription Products
14.2.1.2.1. Nicotine
Sprays (NRT)
14.2.1.2.2. Nicotine
Inhalers (NRT)
14.2.2. Without
Nicotine
14.2.2.1. OTC Products
14.2.2.1.1. E-cigarettes
14.2.2.1.1.1. Open System
14.2.2.1.1.2. Closed System
14.2.2.2. Prescription Products
14.2.2.2.1. Zyban
14.2.2.2.2. Chantix
14.3. Latin
America Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.3.1. Online
14.3.2. Offline
14.3.2.1. Single-brand Vape Stores
14.3.2.2. Multi-brand Vape Stores
14.3.2.3. Retail Stores
14.4. Latin
America Smoking Cessation and Nicotine de-addiction Market Revenue (US$ Mn) and
Forecasts, By Country
14.4.1. Brazil
14.4.1.1. Brazil Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
14.4.1.1.1. With
Nicotine
14.4.1.1.1.1. OTC
Products
14.4.1.1.1.1.1. E-cigarettes
14.4.1.1.1.1.1.1. Open System
14.4.1.1.1.1.1.2. Closed System
14.4.1.1.1.1.2. Nicotine Gums (NRT)
14.4.1.1.1.1.3. Nicotine Patches (NRT)
14.4.1.1.1.1.4. Nicotine Lozenges (NRT)
14.4.1.1.1.1.5. Nicotine Tablets (NRT)
14.4.1.1.1.2. Prescription
Products
14.4.1.1.1.2.1. Nicotine Sprays (NRT)
14.4.1.1.1.2.2. Nicotine Inhalers (NRT)
14.4.1.1.2. Without
Nicotine
14.4.1.1.2.1. OTC
Products
14.4.1.1.2.1.1. E-cigarettes
14.4.1.1.2.1.1.1. Open System
14.4.1.1.2.1.1.2. Closed System
14.4.1.1.2.2. Prescription
Products
14.4.1.1.2.2.1. Zyban
14.4.1.1.2.2.2. Chantix
14.4.1.2. Brazil Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.4.1.2.1. Online
14.4.1.2.2. Offline
14.4.1.2.2.1. Single-brand
Vape Stores
14.4.1.2.2.2. Multi-brand
Vape Stores
14.4.1.2.2.3. Retail
Stores
14.4.2. Argentina
14.4.2.1. Argentina Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Product Type
14.4.2.1.1. With
Nicotine
14.4.2.1.1.1. OTC
Products
14.4.2.1.1.1.1. E-cigarettes
14.4.2.1.1.1.1.1. Open System
14.4.2.1.1.1.1.2. Closed System
14.4.2.1.1.1.2. Nicotine Gums (NRT)
14.4.2.1.1.1.3. Nicotine Patches (NRT)
14.4.2.1.1.1.4. Nicotine Lozenges (NRT)
14.4.2.1.1.1.5. Nicotine Tablets (NRT)
14.4.2.1.1.2. Prescription
Products
14.4.2.1.1.2.1. Nicotine Sprays (NRT)
14.4.2.1.1.2.2. Nicotine Inhalers (NRT)
14.4.2.1.2. Without
Nicotine
14.4.2.1.2.1. OTC
Products
14.4.2.1.2.1.1. E-cigarettes
14.4.2.1.2.1.1.1. Open System
14.4.2.1.2.1.1.2. Closed System
14.4.2.1.2.2. Prescription
Products
14.4.2.1.2.2.1. Zyban
14.4.2.1.2.2.2. Chantix
14.4.2.2. Argentina Smoking Cessation and Nicotine de-addiction Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.4.2.2.1. Online
14.4.2.2.2. Offline
14.4.2.2.2.1. Single-brand
Vape Stores
14.4.2.2.2.2. Multi-brand
Vape Stores
14.4.2.2.2.3. Retail
Stores
14.4.3. Rest of
Latin America
14.4.3.1. Rest of Latin America Smoking Cessation and Nicotine
de-addiction Market Revenue (US$ Mn) and Forecasts, By Product Type
14.4.3.1.1. With
Nicotine
14.4.3.1.1.1. OTC
Products
14.4.3.1.1.1.1. E-cigarettes
14.4.3.1.1.1.1.1. Open System
14.4.3.1.1.1.1.2. Closed System
14.4.3.1.1.1.2. Nicotine Gums (NRT)
14.4.3.1.1.1.3. Nicotine Patches (NRT)
14.4.3.1.1.1.4. Nicotine Lozenges (NRT)
14.4.3.1.1.1.5. Nicotine Tablets (NRT)
14.4.3.1.1.2. Prescription
Products
14.4.3.1.1.2.1. Nicotine Sprays (NRT)
14.4.3.1.1.2.2. Nicotine Inhalers (NRT)
14.4.3.1.2. Without
Nicotine
14.4.3.1.2.1. OTC
Products
14.4.3.1.2.1.1. E-cigarettes
14.4.3.1.2.1.1.1. Open System
14.4.3.1.2.1.1.2. Closed System
14.4.3.1.2.2. Prescription
Products
14.4.3.1.2.2.1. Zyban
14.4.3.1.2.2.2. Chantix
14.4.3.2. Rest of Latin America Smoking Cessation and Nicotine
de-addiction Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.4.3.2.1. Online
14.4.3.2.2. Offline
14.4.3.2.2.1. Single-brand
Vape Stores
14.4.3.2.2.2. Multi-brand
Vape Stores
14.4.3.2.2.3. Retail
Stores
14.5. Key
Segment for Channeling Investments
14.5.1. By
Country
14.5.2. By
Product Type
14.5.3. By
Distribution Channel
15. Competitive Benchmarking
15.1. Market
Share Analysis, 2018
15.2. Global
Presence and Growth Strategies
15.2.1. Mergers
and Acquisitions
15.2.2. Product
Launches
15.2.3. Investments
Trends
15.2.4. R&D
Initiatives
16. Player Profiles
16.1. 22nd
Century Group, Inc
16.1.1. Company
Details
16.1.2. Company
Overview
16.1.3. Product
Offerings
16.1.4. Key
Developments
16.1.5. Financial
Analysis
16.1.6. SWOT
Analysis
16.1.7. Business
Strategies
16.2. Alkalon
A/S
16.2.1. Company
Details
16.2.2. Company
Overview
16.2.3. Product
Offerings
16.2.4. Key
Developments
16.2.5. Financial
Analysis
16.2.6. SWOT
Analysis
16.2.7. Business
Strategies
16.3. Altria
Group, Inc.
16.3.1. Company
Details
16.3.2. Company
Overview
16.3.3. Product
Offerings
16.3.4. Key
Developments
16.3.5. Financial
Analysis
16.3.6. SWOT
Analysis
16.3.7. Business
Strategies
16.4. British
American Tobacco Plc.
16.4.1. Company
Details
16.4.2. Company
Overview
16.4.3. Product
Offerings
16.4.4. Key
Developments
16.4.5. Financial
Analysis
16.4.6. SWOT
Analysis
16.4.7. Business
Strategies
16.5. Cipla
Ltd.
16.5.1. Company
Details
16.5.2. Company
Overview
16.5.3. Product
Offerings
16.5.4. Key
Developments
16.5.5. Financial
Analysis
16.5.6. SWOT
Analysis
16.5.7. Business
Strategies
16.6. GaiaTrend
SARL
16.6.1. Company
Details
16.6.2. Company
Overview
16.6.3. Product
Offerings
16.6.4. Key
Developments
16.6.5. Financial
Analysis
16.6.6. SWOT
Analysis
16.6.7. Business
Strategies
16.7. GlaxoSmithKline
Plc (GSK)
16.7.1. Company
Details
16.7.2. Company
Overview
16.7.3. Product
Offerings
16.7.4. Key
Developments
16.7.5. Financial
Analysis
16.7.6. SWOT
Analysis
16.7.7. Business
Strategies
16.8. Imperial
Brands Plc.
16.8.1. Company
Details
16.8.2. Company
Overview
16.8.3. Product
Offerings
16.8.4. Key
Developments
16.8.5. Financial
Analysis
16.8.6. SWOT
Analysis
16.8.7. Business
Strategies
16.9. ITC Ltd.
16.9.1. Company
Details
16.9.2. Company
Overview
16.9.3. Product
Offerings
16.9.4. Key
Developments
16.9.5. Financial
Analysis
16.9.6. SWOT
Analysis
16.9.7. Business
Strategies
16.10. Japan
Tobacco Inc.
16.10.1. Company
Details
16.10.2. Company
Overview
16.10.3. Product
Offerings
16.10.4. Key
Developments
16.10.5. Financial
Analysis
16.10.6. SWOT Analysis
16.10.7. Business
Strategies
16.11. Johnson
& Johnson (J & J)
16.11.1. Company
Details
16.11.2. Company
Overview
16.11.3. Product
Offerings
16.11.4. Key
Developments
16.11.5. Financial
Analysis
16.11.6. SWOT
Analysis
16.11.7. Business
Strategies
16.12. Juul
Labs, Inc.
16.12.1. Company
Details
16.12.2. Company
Overview
16.12.3. Product
Offerings
16.12.4. Key Developments
16.12.5. Financial
Analysis
16.12.6. SWOT
Analysis
16.12.7. Business
Strategies
16.13. Pfizer
Inc.
16.13.1. Company
Details
16.13.2. Company
Overview
16.13.3. Product
Offerings
16.13.4. Key
Developments
16.13.5. Financial
Analysis
16.13.6. SWOT
Analysis
16.13.7. Business
Strategies
16.14. Shenzhen
IVPS Technology Co. Ltd.
16.14.1. Company
Details
16.14.2. Company
Overview
16.14.3. Product
Offerings
16.14.4. Key
Developments
16.14.5. Financial
Analysis
16.14.6. SWOT
Analysis
16.14.7. Business
Strategies
16.15. ShenZhen
Joye Technology Co., Ltd.
16.15.1. Company
Details
16.15.2. Company
Overview
16.15.3. Product
Offerings
16.15.4. Key
Developments
16.15.5. Financial
Analysis
16.15.6. SWOT
Analysis
16.15.7. Business
Strategies
16.16. Shenzhen
Kanger Technology Co., Ltd.
16.16.1. Company
Details
16.16.2. Company
Overview
16.16.3. Product
Offerings
16.16.4. Key
Developments
16.16.5. Financial
Analysis
16.16.6. SWOT
Analysis
16.16.7. Business
Strategies
16.17. Takeda
Pharmaceutical Company Ltd.
16.17.1. Company
Details
16.17.2. Company
Overview
16.17.3. Product
Offerings
16.17.4. Key Developments
16.17.5. Financial
Analysis
16.17.6. SWOT
Analysis
16.17.7. Business
Strategies
16.18. Twisp
Pty Ltd.
16.18.1. Company
Details
16.18.2. Company
Overview
16.18.3. Product
Offerings
16.18.4. Key
Developments
16.18.5. Financial
Analysis
16.18.6. SWOT
Analysis
16.18.7. Business Strategies
16.19. Other
Industry Participants
17. Key Findings
Note: This ToC is tentative and
can be changed according to the research study conducted during the course of
report completion.
**Exclusive for Multi-User and
Enterprise User
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.